<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01591005</url>
  </required_header>
  <id_info>
    <org_study_id>NT11386-5/2010</org_study_id>
    <nct_id>NCT01591005</nct_id>
  </id_info>
  <brief_title>SONOlysis in Prevention of Brain Infarctions dUring Carotid Stenting and caroTid EndaRterectomy</brief_title>
  <acronym>SONOBUSTER</acronym>
  <official_title>Risk Reduction of Symptomatic and Silent Brain Infarctions During Carotid Endarterectomy and Carotid Stenting Due to Ultrasound Activation of Endogenous Fibrinolytic System Using Transcranial Doppler Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Ostrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Palacky University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Ostrava</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the project is to demonstrate a fibrinolytic effect of sonothrombolysis (continual
      transcranial Doppler monitoring) using 2 MegaHertz (MHz) diagnostic probe on the reduction of
      risk of brain infarctions due to the activation of endogenous fibrinolytic system during
      carotid endarterectomy (CEA) and carotid stenting (CS). 240 patients indicated for CEA (120
      patients) and CS (120 patients) will be enrolled into the study in order to demonstrate a
      twenty-percent risk reduction of number and volume of brain infarctions detected using MRI
      examination 24 hours after CEA or CS in 5% level of significance. Patients will be randomized
      - subgroup 1 will undergo a 60minute non-diagnostic transcranial Doppler (TCD) monitoring
      during CEA or CS, subgroup 2 will undergo interventions without TCD monitoring. The second
      aim is to compare number of brain infarctions detected using MRI between CEA and CS patients.

      Confirmation of the investigators hypothesis that sonothrombolysis is able to activate
      endogenous fibrinolytic system during CEA or CS with consecutive reduction of the number and
      volume of brain infarcts, can lead to the increase of the safety of CEA and CS in patients
      with internal carotid artery stenosis. The investigators can presume that up to 50% of
      patients indicated for CEA or CS can be treated using these methods in the future.

      In the Substudy &quot;Risk of brain infarction after carotid endarterectomy and stenting&quot; the the
      risk of asymptomatic and symptomatic brain infarctions, changes in cognitive functions, as
      well as morbidity and mortality at 30 days between patients with symptomatic and asymptomatic
      severe internal carotid artery (ICA) stenoses undergoing elective CEA and CAS will be
      compared.

      The sample size of the Substudy was based on an expected 80% difference of new ischemic
      lesions on DWI-MRI between CEA (estimated prevalence, 30%) and CAS (54%). Pre-study
      calculations showed that a minimum of 73 patients in each group was needed to reach a
      significant difference with an alpha value of 0.05 (two-tailed) and a beta value of 0.8
      assuming that 15% of subjects would be lost to follow-up or refuse to participate in the
      study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      AIM OF THE PROJECT AND HYPOTHESIS The aim of the project is to demonstrate an effect of
      continual TCD monitoring using 2 MHz diagnostic probe with maximal diagnostic energy on the
      reduction of risk of brain microinfarctions due to the activation of endogenous fibrinolytic
      system during CEA and CS. The second aim of the study is to compare the risk of brain
      infarction between CEA and CS.

      240 patients indicated for CEA (120 patients) and CS (120 patients) will be enrolled into the
      study in order to demonstrate a twenty-percent risk reduction of number and volume of brain
      infarctions detected using MRI examination 24 hours after CEA or CS in 5% level of
      statistical significance. Patients will be randomized into 2 subgroups. Subgroup 1 will
      undergo a 60minute non-diagnostic TCD monitoring during CEA or CS. Subgroup 2 will undergo
      CEA or CS without TCD monitoring. The second aim is to compare number and volume of brain
      infarctions detected using MRI between CEA and CS patients.

      Substudy &quot;Risk of brain infarction after carotid endarterectomy and stenting&quot; The aim of the
      prospective, randomized study was to compare the risk of asymptomatic and symptomatic brain
      infarctions, changes in cognitive functions, as well as morbidity and mortality at 30 days
      between patients with symptomatic and asymptomatic severe ICA stenoses undergoing elective
      CEA and CS.

      PATIENTS AND METHODS 240 patients with ICA stenosis indicated for CEA or CS according to the
      criteria of the American Heart Association will be enrolled into the study during a 4-year
      period. Altogether 120 patients indicated for CEA and 120 patients indicated for CS will be
      randomized for standard CEA / CS and TCD monitored CEA / CS.

      Randomization: Randomization using computer generated random allocation will be used,
      separately for CEA and CS patients.

      Substudy &quot;Risk of brain infarction after carotid endarterectomy and stenting&quot; Minimally146
      patients with ICA stenosis &gt;70% (symptomatic or asymptomatic) detected by duplex sonography
      and confirmed using computed tomography angiography (CTA); indication for carotid
      intervention (CEA or CAS) according to criteria set by the American Heart Association5; age
      40-80 years; (iv) functionally independent (modified Rankin score 0-2 points); no
      contraindication to magnetic resonance imaging (MRI), computer tomography angiography (CTA)
      or digital angiography (DSA) will be enrolled to the Substudy.

      Randomization: Randomization using computer generated random allocation to CEA or CS will be
      used.

      Sonothrombolysis: In patients randomized into sonothrombolysis subgroup, middle cerebral
      artery (MCA) segment in depth 55 mm will be monitored for 40 minutes using a diagnostic 2 MHz
      probe with maximal diagnostic energy. Non-diagnostic TCD monitoring will be performed without
      detection of microembolic signals or detection of changes in blood flow. The second (control)
      subgroup will undergo a standard CEA or CS without sonothrombolysis.

      MRI protocol will consists of 4 sequences: 1. Localizer; 2. T2-weighted images (T2TSE); 3.
      fluid-attenuated inversion recovery (FLAIR); 4. diffusion-weighted imaging (DWI). Sequences
      1-3 will be applied in the same level, they will have the same slice thickness and the same
      cut number. The slice thickness comprises its own cut thickness (5 mm) + distant factor
      (30%). Standard number of slices is 19. Standard slice level is considered to be a modified
      level of skull base due to the minimalization of distant artifacts echo planar imaging (EPI)
      sequence. Sequence called &quot;trace&quot; with three types of magnetic resonance pictures in every
      slice: (a) T2*EPI b=0; (b) DWI b=500; (c) DWI b=1000. The fourth type of images automatically
      created an apparent diffusion coefficient (ADC) map (in-line postprocessing). DWI show a
      middle (average) diffusivity of every point of examined brain tissue when b value is 500 and
      1000. This sequence is applied in order to assess hemorrhage (T2*EPI) and monitor sites of
      reduced diffusion (DWI, b=500 and 1000). New infarctions will be evaluated only in the
      territory of treated ICA.

      Adverse effects: All adverse effects during 1 month after ultrasound monitoring will be
      registered, especially all causes for new admissions to the hospital, worsening of
      neurological symptoms (&gt;4 points in NIH stroke scale), brain edema, symptomatic and
      asymptomatic intracranial bleeding detected in control brain MRI.

      Statistic evaluation: All statistical tests will be performed at the Department of
      Biophysics, Informatics and Biometry, Palacký University Medical School, Olomouc. Statistical
      evaluation in 5% level of significance of differences in the number and volume of brain
      infarctions detected using MRI between patients with TCD monitoring and without TCD
      monitoring during CEA or CS will be performed using Student T-test, χ2-test, Mann-Whitney
      U-test, ANOVA and multivariate analysis. Differences in the number and volume of brain
      infarctions between patients after CEA and CS will be evaluated as secondary end-points.
      Influence of other factors, e.g. age, gender, symptoms in the territory of treated artery,
      number of infarctions before CEA or CS, results of cognitive tests will be evaluated.

      Statistic evaluation for Substudy: The normality of distribution of all data will be checked
      using the Shapiro-Wilk test. Categorical variables in the two arms will be compared by
      Fisher's exact test. Continuous variables will be compared by the Student's t-test for
      normally distributed values and by Mann-Whitney U test for other values. Multiple logistic
      regression analyses were used to determine the possible predictors of a new brain infarction.
      All tests were carried out at an alpha level of significance of 0.05.

      Study protocol has been approved by the Ethics Committees in accordance with the principles
      and guidelines of the Declaration of Helsinki, 1975.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Participants With a New Brain Infarction Detected Using Magnetic Resonance</measure>
    <time_frame>24 hours after intervention</time_frame>
    <description>The number of participants with a new brain infarctions in sonolysis group detected using magnetic resonance examination 24 hours after carotid endarterectomy or carotid stenting.
Substudy: The number of participants with a new brain infarctions on brain diffusion-weighted magnetic resonance imaging performed 24 hours after intervention in carotid endarterectomy and carotid stenting groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participants With a New Brain Infarctions Detected Using Magnetic Resonance in Endarterectomy and Stenting Groups</measure>
    <time_frame>24 hours after intervention</time_frame>
    <description>The number of participants with a new brain infarctions &gt;0.5 cm3 detected using magnetic resonance examination 24 hours after intervention between endarterectomy and stenting using periprocedural sonolysis.
Substudy: The number of participants with a new brain infarctions &gt;0.5 cm3 detected using magnetic resonance examination 24 hours after intervention between carotid endarterectomy and carotid stenting groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Decline</measure>
    <time_frame>24 hours after intervention</time_frame>
    <description>The changes in cognitive functions after carotid endarterectomy and carotid stenting measured by Mini-Mental State Examination using periprocedural sonolysis.
Substudy: The changes in cognitive functions after intervention measured by Mini-Mental State Examination between carotid endarterectomy and carotid stenting groups.
Range of scores possible for the Mini-Mental State Examination: 0 - 30 points. Higher values in this range are considered to be a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Clinical Manifested Brain Infarction</measure>
    <time_frame>24 hours and 30 days after intervention</time_frame>
    <description>The risk of stroke or transient ischemic attack (at 24 hours and 30 days) due to the activation of endogenous fibrinolytic system during carotid endarterectomy and carotid stenting using periprocedural sonolysis.
Substudy: The risk of stroke or transient ischemic attack (at 24 hours and 30 days) due to the activation of endogenous fibrinolytic system between carotid endarterectomy and carotid stenting groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participatns With New Ipsilateral Brain Infarctions Detected Using MRI in Endarterectomy and Stenting Groups</measure>
    <time_frame>24 hours after intervention</time_frame>
    <description>The number of patients with the ipsilateral brain infarctions detected using MRI examination 24 hours after intervention between endarterectomy and stenting using periprocedural sonolysis.
Substudy: The number of patients with the ipsilateral brain infarctions detected using MRI examination 24 hours after intervention between carotid endarterectomy and carotid stenting groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Clinical Vascular Event or Death</measure>
    <time_frame>30 days after intervention</time_frame>
    <description>The risk of the occurrence of death, any stroke, or myocardial infarction within 30 days (myocardial infarction was defined as a post-interventional cardiac troponin T level increase &gt;2-fold the upper limit of normal in addition to either chest pain or symptoms consistent with ischemia or electrocardiographic evidence of ischemia) after carotid endarterectomy and carotid stenting using periprocedural sonolysis.
Substudy: The risk of the occurrence of death, any stroke, or myocardial infarction within 30 days (myocardial infarction was defined as a post-interventional cardiac troponin T level increase &gt;2-fold the upper limit of normal in addition to either chest pain or symptoms consistent with ischemia or electrocardiographic evidence of ischemia) between carotid endarterectomy and carotid stenting groups.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Participants With Complications</measure>
    <time_frame>24 hours and 30 days after intervention</time_frame>
    <description>Any complication during carotid endarterectomy and carotid stenting, sonolysis or 30 days after intervention in all subgroups.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">242</enrollment>
  <condition>Internal Carotid Artery Stenosis</condition>
  <arm_group>
    <arm_group_label>CEA with sonolysis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>endarterectomy with sonolysis (continual transcranial Doppler monitoring)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CEA without sonolysis</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>endarterectomy without sonolysis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>carotid stenting with sonolysis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>carotid stenting with sonolysis (continual transcranial Doppler monitoring)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>carotid stenting without sonolysis</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>carotid stenting without sonolysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sonolysis</intervention_name>
    <description>continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes</description>
    <arm_group_label>CEA with sonolysis</arm_group_label>
    <arm_group_label>carotid stenting with sonolysis</arm_group_label>
    <other_name>sonothrombolysis</other_name>
    <other_name>sonothrombotripsy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endarterectomy</intervention_name>
    <description>carotid endarterectomy</description>
    <arm_group_label>CEA with sonolysis</arm_group_label>
    <arm_group_label>CEA without sonolysis</arm_group_label>
    <other_name>carotid endarterectomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>carotid stenting</intervention_name>
    <description>percutaneous transluminal angioplasty and stenting</description>
    <arm_group_label>carotid stenting with sonolysis</arm_group_label>
    <arm_group_label>carotid stenting without sonolysis</arm_group_label>
    <other_name>percutaneous transluminal angioplasty and stenting</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stenosis of internal carotid artery

          -  indication to endarterectomy or stenting

          -  age 40-80 years

          -  sufficient temporal bone window for TCD with detectable blood flow in MCA

          -  independent patient (modified Rankin score 0-2)

          -  informed consent signed by the patient.

        Exclusion Criteria:

          -  contraindication to MRI examination (pace-maker, implanted metal material,
             claustrophobia)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Skoloudik, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Ostrava</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Ostrava</name>
      <address>
        <city>Ostrava</city>
        <zip>70852</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <link>
    <url>http://fno.cz</url>
    <description>University Hospital Ostrava</description>
  </link>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2012</study_first_submitted>
  <study_first_submitted_qc>May 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 3, 2012</study_first_posted>
  <results_first_submitted>December 22, 2015</results_first_submitted>
  <results_first_submitted_qc>July 24, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 8, 2016</results_first_posted>
  <last_update_submitted>July 24, 2016</last_update_submitted>
  <last_update_submitted_qc>July 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Ostrava</investigator_affiliation>
    <investigator_full_name>Vaclav Prochazka, MD, PhD. MSc</investigator_full_name>
    <investigator_title>Vaclav Prochazka, MD, PhD, MSc</investigator_title>
  </responsible_party>
  <keyword>sonolysis</keyword>
  <keyword>carotid</keyword>
  <keyword>endarterectomy</keyword>
  <keyword>stenting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Carotid Stenosis</mesh_term>
    <mesh_term>Brain Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>CEA With Sonolysis</title>
          <description>endarterectomy with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
endarterectomy: carotid endarterectomy</description>
        </group>
        <group group_id="P2">
          <title>CEA Without Sonolysis</title>
          <description>endarterectomy without sonolysis
endarterectomy: carotid endarterectomy</description>
        </group>
        <group group_id="P3">
          <title>Carotid Stenting With Sonolysis</title>
          <description>carotid stenting with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
        </group>
        <group group_id="P4">
          <title>Carotid Stenting Without Sonolysis</title>
          <description>carotid stenting without sonolysis
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
                <participants group_id="P2" count="53"/>
                <participants group_id="P3" count="68"/>
                <participants group_id="P4" count="68"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
                <participants group_id="P2" count="53"/>
                <participants group_id="P3" count="68"/>
                <participants group_id="P4" count="68"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>In total, 242 of the 495 screened patients fulfilled the inclusion criteria. Subjects were randomly and equally allocated to the sonolysis or control group. Clinical and procedural variables were well balanced between the groups</population>
      <group_list>
        <group group_id="B1">
          <title>CEA With Sonolysis</title>
          <description>endarterectomy with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
endarterectomy: carotid endarterectomy</description>
        </group>
        <group group_id="B2">
          <title>CEA Without Sonolysis</title>
          <description>endarterectomy without sonolysis
endarterectomy: carotid endarterectomy</description>
        </group>
        <group group_id="B3">
          <title>Carotid Stenting With Sonolysis</title>
          <description>carotid stenting with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
        </group>
        <group group_id="B4">
          <title>Carotid Stenting Without Sonolysis</title>
          <description>carotid stenting without sonolysis
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="53"/>
            <count group_id="B2" value="53"/>
            <count group_id="B3" value="68"/>
            <count group_id="B4" value="68"/>
            <count group_id="B5" value="242"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.0" spread="7.3"/>
                    <measurement group_id="B2" value="63.0" spread="7.5"/>
                    <measurement group_id="B3" value="66.8" spread="6.7"/>
                    <measurement group_id="B4" value="68.5" spread="7.7"/>
                    <measurement group_id="B5" value="65.8" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="24"/>
                    <measurement group_id="B5" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="53"/>
                    <measurement group_id="B4" value="44"/>
                    <measurement group_id="B5" value="162"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Czech Republic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                    <measurement group_id="B2" value="53"/>
                    <measurement group_id="B3" value="68"/>
                    <measurement group_id="B4" value="68"/>
                    <measurement group_id="B5" value="242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Participants With a New Brain Infarction Detected Using Magnetic Resonance</title>
        <description>The number of participants with a new brain infarctions in sonolysis group detected using magnetic resonance examination 24 hours after carotid endarterectomy or carotid stenting.
Substudy: The number of participants with a new brain infarctions on brain diffusion-weighted magnetic resonance imaging performed 24 hours after intervention in carotid endarterectomy and carotid stenting groups.</description>
        <time_frame>24 hours after intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Carotid Endarterectomy With Sonolysis</title>
            <description>endarterectomy with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O2">
            <title>Carotid Endarterectomy Without Sonolysis</title>
            <description>endarterectomy without sonolysis
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O3">
            <title>Carotid Stenting With Sonolysis</title>
            <description>carotid stenting with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
          <group group_id="O4">
            <title>Carotid Stenting Without Sonolysis</title>
            <description>carotid stenting without sonolysis
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
        </group_list>
        <measure>
          <title>Participants With a New Brain Infarction Detected Using Magnetic Resonance</title>
          <description>The number of participants with a new brain infarctions in sonolysis group detected using magnetic resonance examination 24 hours after carotid endarterectomy or carotid stenting.
Substudy: The number of participants with a new brain infarctions on brain diffusion-weighted magnetic resonance imaging performed 24 hours after intervention in carotid endarterectomy and carotid stenting groups.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="68"/>
                <count group_id="O4" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="33"/>
                    <measurement group_id="O4" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participants With a New Brain Infarctions Detected Using Magnetic Resonance in Endarterectomy and Stenting Groups</title>
        <description>The number of participants with a new brain infarctions &gt;0.5 cm3 detected using magnetic resonance examination 24 hours after intervention between endarterectomy and stenting using periprocedural sonolysis.
Substudy: The number of participants with a new brain infarctions &gt;0.5 cm3 detected using magnetic resonance examination 24 hours after intervention between carotid endarterectomy and carotid stenting groups.</description>
        <time_frame>24 hours after intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Carotid Endarterectomy With Sonolysis</title>
            <description>endarterectomy with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O2">
            <title>Carotid Endarterectomy Without Sonolysis</title>
            <description>endarterectomy without sonolysis
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O3">
            <title>Carotid Stenting With Sonolysis</title>
            <description>carotid stenting with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
          <group group_id="O4">
            <title>Carotid Stenting Without Sonolysis</title>
            <description>carotid stenting without sonolysis
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
        </group_list>
        <measure>
          <title>Participants With a New Brain Infarctions Detected Using Magnetic Resonance in Endarterectomy and Stenting Groups</title>
          <description>The number of participants with a new brain infarctions &gt;0.5 cm3 detected using magnetic resonance examination 24 hours after intervention between endarterectomy and stenting using periprocedural sonolysis.
Substudy: The number of participants with a new brain infarctions &gt;0.5 cm3 detected using magnetic resonance examination 24 hours after intervention between carotid endarterectomy and carotid stenting groups.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="68"/>
                <count group_id="O4" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cognitive Decline</title>
        <description>The changes in cognitive functions after carotid endarterectomy and carotid stenting measured by Mini-Mental State Examination using periprocedural sonolysis.
Substudy: The changes in cognitive functions after intervention measured by Mini-Mental State Examination between carotid endarterectomy and carotid stenting groups.
Range of scores possible for the Mini-Mental State Examination: 0 - 30 points. Higher values in this range are considered to be a better outcome.</description>
        <time_frame>24 hours after intervention</time_frame>
        <population>only patients with performed Mini Mental State examination</population>
        <group_list>
          <group group_id="O1">
            <title>Carotid Endarterectomy With Sonolysis</title>
            <description>endarterectomy with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O2">
            <title>Carotid Endarterectomy Without Sonolysis</title>
            <description>endarterectomy without sonolysis
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O3">
            <title>Carotid Stenting With Sonolysis</title>
            <description>carotid stenting with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
          <group group_id="O4">
            <title>Carotid Stenting Without Sonolysis</title>
            <description>carotid stenting without sonolysis
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
        </group_list>
        <measure>
          <title>Cognitive Decline</title>
          <description>The changes in cognitive functions after carotid endarterectomy and carotid stenting measured by Mini-Mental State Examination using periprocedural sonolysis.
Substudy: The changes in cognitive functions after intervention measured by Mini-Mental State Examination between carotid endarterectomy and carotid stenting groups.
Range of scores possible for the Mini-Mental State Examination: 0 - 30 points. Higher values in this range are considered to be a better outcome.</description>
          <population>only patients with performed Mini Mental State examination</population>
          <units>Scores on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="37"/>
                <count group_id="O3" value="47"/>
                <count group_id="O4" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28" lower_limit="26" upper_limit="29"/>
                    <measurement group_id="O2" value="27" lower_limit="25" upper_limit="28"/>
                    <measurement group_id="O3" value="28" lower_limit="26" upper_limit="29"/>
                    <measurement group_id="O4" value="27" lower_limit="25" upper_limit="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Clinical Manifested Brain Infarction</title>
        <description>The risk of stroke or transient ischemic attack (at 24 hours and 30 days) due to the activation of endogenous fibrinolytic system during carotid endarterectomy and carotid stenting using periprocedural sonolysis.
Substudy: The risk of stroke or transient ischemic attack (at 24 hours and 30 days) due to the activation of endogenous fibrinolytic system between carotid endarterectomy and carotid stenting groups.</description>
        <time_frame>24 hours and 30 days after intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Carotid Endarterectomy With Sonolysis</title>
            <description>endarterectomy with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O2">
            <title>Carotid Endarterectomy Without Sonolysis</title>
            <description>endarterectomy without sonolysis
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O3">
            <title>Carotid Stenting With Sonolysis</title>
            <description>carotid stenting with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
          <group group_id="O4">
            <title>Carotid Stenting Without Sonolysis</title>
            <description>carotid stenting without sonolysis
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Clinical Manifested Brain Infarction</title>
          <description>The risk of stroke or transient ischemic attack (at 24 hours and 30 days) due to the activation of endogenous fibrinolytic system during carotid endarterectomy and carotid stenting using periprocedural sonolysis.
Substudy: The risk of stroke or transient ischemic attack (at 24 hours and 30 days) due to the activation of endogenous fibrinolytic system between carotid endarterectomy and carotid stenting groups.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="68"/>
                <count group_id="O4" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participatns With New Ipsilateral Brain Infarctions Detected Using MRI in Endarterectomy and Stenting Groups</title>
        <description>The number of patients with the ipsilateral brain infarctions detected using MRI examination 24 hours after intervention between endarterectomy and stenting using periprocedural sonolysis.
Substudy: The number of patients with the ipsilateral brain infarctions detected using MRI examination 24 hours after intervention between carotid endarterectomy and carotid stenting groups.</description>
        <time_frame>24 hours after intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Carotid Endarterectomy With Sonolysis</title>
            <description>endarterectomy with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O2">
            <title>Carotid Endarterectomy Without Sonolysis</title>
            <description>endarterectomy without sonolysis
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O3">
            <title>Carotid Stenting With Sonolysis</title>
            <description>carotid stenting with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
          <group group_id="O4">
            <title>Carotid Stenting Without Sonolysis</title>
            <description>carotid stenting without sonolysis
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participatns With New Ipsilateral Brain Infarctions Detected Using MRI in Endarterectomy and Stenting Groups</title>
          <description>The number of patients with the ipsilateral brain infarctions detected using MRI examination 24 hours after intervention between endarterectomy and stenting using periprocedural sonolysis.
Substudy: The number of patients with the ipsilateral brain infarctions detected using MRI examination 24 hours after intervention between carotid endarterectomy and carotid stenting groups.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="68"/>
                <count group_id="O4" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="26"/>
                    <measurement group_id="O4" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Clinical Vascular Event or Death</title>
        <description>The risk of the occurrence of death, any stroke, or myocardial infarction within 30 days (myocardial infarction was defined as a post-interventional cardiac troponin T level increase &gt;2-fold the upper limit of normal in addition to either chest pain or symptoms consistent with ischemia or electrocardiographic evidence of ischemia) after carotid endarterectomy and carotid stenting using periprocedural sonolysis.
Substudy: The risk of the occurrence of death, any stroke, or myocardial infarction within 30 days (myocardial infarction was defined as a post-interventional cardiac troponin T level increase &gt;2-fold the upper limit of normal in addition to either chest pain or symptoms consistent with ischemia or electrocardiographic evidence of ischemia) between carotid endarterectomy and carotid stenting groups.</description>
        <time_frame>30 days after intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Carotid Endarterectomy With Sonolysis</title>
            <description>endarterectomy with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O2">
            <title>Carotid Endarterectomy Without Sonolysis</title>
            <description>endarterectomy without sonolysis
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O3">
            <title>Carotid Stenting With Sonolysis</title>
            <description>carotid stenting with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
          <group group_id="O4">
            <title>Carotid Stenting Without Sonolysis</title>
            <description>carotid stenting without sonolysis
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Clinical Vascular Event or Death</title>
          <description>The risk of the occurrence of death, any stroke, or myocardial infarction within 30 days (myocardial infarction was defined as a post-interventional cardiac troponin T level increase &gt;2-fold the upper limit of normal in addition to either chest pain or symptoms consistent with ischemia or electrocardiographic evidence of ischemia) after carotid endarterectomy and carotid stenting using periprocedural sonolysis.
Substudy: The risk of the occurrence of death, any stroke, or myocardial infarction within 30 days (myocardial infarction was defined as a post-interventional cardiac troponin T level increase &gt;2-fold the upper limit of normal in addition to either chest pain or symptoms consistent with ischemia or electrocardiographic evidence of ischemia) between carotid endarterectomy and carotid stenting groups.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="68"/>
                <count group_id="O4" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Participants With Complications</title>
        <description>Any complication during carotid endarterectomy and carotid stenting, sonolysis or 30 days after intervention in all subgroups.</description>
        <time_frame>24 hours and 30 days after intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Carotid Endarterectomy With Sonolysis</title>
            <description>endarterectomy with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O2">
            <title>Carotid Endarterectomy Without Sonolysis</title>
            <description>endarterectomy without sonolysis
endarterectomy: carotid endarterectomy</description>
          </group>
          <group group_id="O3">
            <title>Carotid Stenting With Sonolysis</title>
            <description>carotid stenting with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
          <group group_id="O4">
            <title>Carotid Stenting Without Sonolysis</title>
            <description>carotid stenting without sonolysis
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Complications</title>
          <description>Any complication during carotid endarterectomy and carotid stenting, sonolysis or 30 days after intervention in all subgroups.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="53"/>
                <count group_id="O3" value="68"/>
                <count group_id="O4" value="68"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 month</time_frame>
      <group_list>
        <group group_id="E1">
          <title>CEA With Sonolysis</title>
          <description>endarterectomy with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
endarterectomy: carotid endarterectomy</description>
        </group>
        <group group_id="E2">
          <title>CEA Without Sonolysis</title>
          <description>endarterectomy without sonolysis
endarterectomy: carotid endarterectomy</description>
        </group>
        <group group_id="E3">
          <title>Carotid Stenting With Sonolysis</title>
          <description>carotid stenting with sonolysis (continual transcranial Doppler monitoring)
sonolysis: continual transcranial Doppler monitoring with max. diagnostic intensity for 60 minutes
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
        </group>
        <group group_id="E4">
          <title>Carotid Stenting Without Sonolysis</title>
          <description>carotid stenting without sonolysis
carotid stenting: percutaneous transluminal angioplasty and stenting</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="68"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="68"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Serial follow-up MRI was not done. A software package for mapping of brain infarction volume was not used. Single-centre investigation with mandatory use of brain protection device during carotid stenting and shunt during carotid endarterectomy.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Prof. David Skoloudik, MD, Ph.D.</name_or_title>
      <organization>University Hospital Ostrava</organization>
      <phone>+420597375613</phone>
      <email>skoloudik@hotmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

